Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study

被引：0
|
作者：
Gabriela Grimaldi
Giuseppe Cancian
Angelica Rizzato
Alex Casanova
Kathrin Perruchoud-Ader
Michele Clerici
Andrea Consigli
Moreno Menghini
机构：
[1] Ente Ospedaliero Cantonale (EOC),Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI)
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2024年 / 262卷
关键词：
Faricimab; Age-related macular degeneration; Treat-and-extend; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1151 / 1159
页数：8
相关论文
共 50 条
  • [21] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab
    Zehetner, C.
    Kralinger, M. T.
    Kieselbach, G. F.
    SPEKTRUM DER AUGENHEILKUNDE, 2008, 22 (06) : 370 - 375
  • [22] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [23] Outcomes of Intravitreal Aflibercept 8 mg in Eyes With Neovascular Age-Related Macular Degeneration Previously Treated With Faricimab
    Momenaei, Bita
    Yonekawa, Yoshihiro
    Abril, Paige
    Mccullough, Rachel
    Abbey, Ashkan M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2025,
  • [24] Vitreomacular Interface in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration
    Onen, Mehmet
    Kayhan, Ayse Metin
    Yazar, Zeliha
    Ucgun, Nil Irem
    Sarikatipoglu, Hikmet
    OPHTHALMOLOGICA, 2014, 232 : 11 - 11
  • [25] Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
    Campa, C.
    Harding, S. P.
    CURRENT DRUG TARGETS, 2011, 12 (02) : 173 - 181
  • [26] Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
    Pandit, Saagar A.
    Momenaei, Bita
    Wakabayashi, Taku
    Mansour, Hana A.
    Vemula, Sudheshna
    Durrani, Asad F.
    Pashaee, Bahram
    Kazan, Adina S.
    Ho, Allen C.
    Klufas, Michael
    Regillo, Carl
    Yonekawa, Yoshihiro
    Hsu, Jason
    Kuriyan, Ajay
    Chiang, Allen
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 360 - 366
  • [27] ANTI-VEGF TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN AUSTRALIA
    Finger, Robert
    Fotis, Kathy
    Cummins, Rob
    Heraghty, Julie
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 14 - 14
  • [28] Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
    Korva-Gurung, Ida
    Kubin, Anna-Maria
    Ohtonen, Pasi
    Hautala, Nina
    PHARMACEUTICALS, 2023, 16 (07)
  • [29] Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
    Armendariz, Beatriz G.
    Chakravarthy, Usha
    EYE, 2024, 38 (17) : 3243 - 3251
  • [30] Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
    Costagliola, Ciro
    Agnifili, Luca
    Arcidiacono, Barbara
    Duse, Sarah
    Fasanella, Vincenzo
    Mastropasqua, Rodolfo
    Verolino, Marco
    Semeraro, Francesco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1299 - 1313
12345